Medinotec Book Value Per Share Growth & History (MDNC)
Medinotec's book value per share was $0.49 for fiscal 2026.
View full Medinotec company overviewMedinotec annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-02-28 | $0.49 | $0.12 | +33.48% |
| 2025 | 2025-02-28 | $0.36 | $0.18 | +97.07% |
| 2024 | 2024-02-29 | $0.18 | -$0.03 | −15.21% |
| 2023 | 2023-02-28 | $0.22 | $47.22 | — |
| 2022 | 2022-02-28 | -$47.00 | — | — |
Medinotec quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-05-31 | $0.50 | $0.13 | +33.96% |
| Q4 2026 | 2026-02-28 | $0.49 | $0.12 | +33.48% |
| Q3 2026 | 2025-11-30 | $0.47 | $0.23 | +94.28% |
| Q2 2026 | 2025-08-31 | $0.41 | $0.20 | +90.87% |
| Q1 2026 | 2025-05-31 | $0.37 | $0.18 | +93.79% |
| Q4 2025 · Feb 28 | 2025-02-28 | $0.36 | $0.18 | +97.07% |
| Q3 2025 | 2024-11-30 | $0.24 | $0.06 | +36.17% |
| Q2 2025 | 2024-08-31 | $0.22 | -$0.00 | −1.46% |
| Q1 2025 | 2024-05-31 | $0.19 | -$0.03 | −14.21% |
| Q4 2024 | 2024-02-29 | $0.18 | -$0.03 | −15.21% |
| Q3 2024 | 2023-11-30 | $0.18 | -$0.07 | −29.52% |
| Q2 2024 | 2023-08-31 | $0.22 | — | — |
| Q1 2024 | 2023-05-31 | $0.22 | — | — |
| Q4 2023 | 2023-02-28 | $0.22 | $47.22 | — |
| Q3 2023 | 2022-11-30 | $0.25 | — | — |
| Q4 2022 | 2022-02-28 | -$47.00 | — | — |
Medinotec book value per share trends
Between the periods ended 2022-02-28 and 2026-02-28, Medinotec's book value per share increased from -$47.00 to $0.49, a change of $47.48. The latest reported quarter, Q1 2027, shows $0.50.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medinotec source filings ↗